ALT — Analytica Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Analytica, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.01 | 0.83 | 0.81 | 0.802 | 0.287 |
| Cost of Revenue | |||||
| Gross Profit | 0.989 | 0.812 | 0.793 | 0.798 | 0.278 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.17 | 2.88 | 2.43 | 2.31 | 2.53 |
| Operating Profit | -2.16 | -2.05 | -1.62 | -1.51 | -2.24 |
| Net Income Before Taxes | -2.16 | -2.05 | -1.62 | -1.51 | -2.24 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.16 | -2.05 | -1.62 | -1.51 | -2.24 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.16 | -2.05 | -1.62 | -1.51 | -2.24 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.16 | -2.05 | -1.62 | -1.51 | -2.24 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.001 | -0 | -0 | -0.001 |